|
OHDSI Phenotype Phebruary 2024 and workgroup updates
|
|
59
|
1209
|
October 28, 2024
|
|
Medication-Related Osteonecrosis of the Jaw: Dentistry Phenotype
|
|
1
|
448
|
February 9, 2024
|
|
Phenotype Phebruary 2023 - P11 - Neurofibromatosis type 1 with Optical Pathway Glioma
|
|
6
|
632
|
April 25, 2023
|
|
Phenotype Phebruary 2023 P8 Parkinson's disease
|
|
44
|
1078
|
March 23, 2023
|
|
Phenotype Phebruary 2023 - P5 - Systemic Lupus Erythematosus (SLE)
|
|
14
|
788
|
March 17, 2023
|
|
Phenotype Phebruary 2023 - Announcements
|
|
27
|
1011
|
February 28, 2023
|
|
Phenotype Phebrurary 2023 - P10 - Neonatal Hypoxic Ischemic Encephalopathy
|
|
11
|
886
|
February 28, 2023
|
|
Phenotype Phebruary 2023 - Week 2 - Debate - Chart review gold standard validation vs innovative methods like PheValuator
|
|
16
|
929
|
February 27, 2023
|
|
Phenotype Phebruary 2023 - Week 3 - Debate – customized versus standardized approach for Phenotype development and evaluation
|
|
8
|
642
|
February 27, 2023
|
|
Phenotype Phebrurary 2023 - P7 - Adult dermatomyositis
|
|
6
|
571
|
February 24, 2023
|
|
Phenotype Phebrurary 2023 – P9 – ST Elevation Myocardial Infarction
|
|
11
|
811
|
February 24, 2023
|
|
Phenotype Phebrurary 2023 - P6 - Acute Hepatic Failure
|
|
8
|
648
|
February 23, 2023
|
|
Phenotype Phebruary 2023 - Week 4 – Discussion – How can we couple probabilistic and rule based phenotyping in a systematic process to improve the development and evaluation of phenotypes?
|
|
0
|
348
|
February 21, 2023
|
|
Phenotype Phebrurary 2023 - P2 - Anaphylaxis
|
|
11
|
702
|
February 12, 2023
|
|
Phenotype Phebruary 2023 - Week 1 Discussion - Phenotype Peer Review
|
|
25
|
796
|
February 7, 2023
|
|
Phenotype Phebruary 2023 - P4 - Acquired Neutropenia
|
|
3
|
547
|
February 6, 2023
|
|
Phenotype Phebrurary 2023 - P1 - Acute Pancreatitis
|
|
6
|
784
|
February 6, 2023
|
|
Phenotype Phebruary 2023 - P3 - Appendicitis - interactive session
|
|
4
|
667
|
February 5, 2023
|
